Neuphoria Therapeutics(NEUP)
$2.71+0.02 (+0.74%)
NEUP
Neuphoria Therapeutics financials statements
$2.71
At close:+0.02 (+0.74%)
Want to see NEUP full AI Analyst Report?
Neuphoria Therapeutics (NEUP) Financial Statements
301 Followers
Neuphoria Therapeutics Financial Overview
Neuphoria Therapeutics's market cap is currently AU$14.56M. The company's EPS TTM is AU$-7.26; its P/E ratio is -0.37; Neuphoria Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | AU$ 1.17M | AU$ 15.65M | AU$ 0.00 | AU$ 0.00 | AU$ 383.16K |
| Gross Profit | AU$ 511.21K | AU$ 14.99M | AU$ -662.99K | AU$ -671.48K | AU$ -9.98M |
| Operating Income | AU$ -9.81M | AU$ -1.13M | AU$ -26.79M | AU$ -33.09M | AU$ -31.02M |
| EBITDA | AU$ -9.15M | AU$ -466.20K | AU$ -25.98M | AU$ -31.48M | AU$ -30.75M |
| Net Income | AU$ -13.45M | AU$ -369.63K | AU$ -15.49M | AU$ -32.18M | AU$ -22.94M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | AU$ 19.87B | AU$ 21.59M | AU$ 12.61M | AU$ 8.06M | AU$ 33.56M |
| Total Assets | AU$ 28.71B | AU$ 43.44M | AU$ 27.65M | AU$ 19.39M | AU$ 65.30M |
| Total Debt | AU$ 34.34K | AU$ 226.49K | AU$ 272.74K | AU$ 582.35K | AU$ 693.55K |
| Net Debt | AU$ -19.87B | AU$ -21.37M | AU$ -12.34M | AU$ -7.80M | AU$ -32.87M |
| Total Liabilities | AU$ 4.11B | AU$ 14.57M | AU$ 10.16M | AU$ 4.74M | AU$ 8.40M |
| Stockholders' Equity | AU$ 24.60B | AU$ 28.87M | AU$ 17.49M | AU$ 14.65M | AU$ 56.91M |
| Cash Flow | |||||
| Free Cash Flow | AU$ -12.35M | AU$ 77.23M | AU$ -14.68M | AU$ -9.85M | AU$ -21.75M |
| Operating Cash Flow | AU$ -12.35M | AU$ 77.23M | AU$ -14.68M | AU$ -9.85M | AU$ -21.75M |
| Investing Cash Flow | AU$ 0.00 | AU$ 0.00 | AU$ 0.00 | AU$ 0.00 | AU$ 621.64K |
| Financing Cash Flow | AU$ 17.92M | AU$ 1.53B | AU$ 15.11M | AU$ 5.81M | AU$ 26.99M |
Currency in AUD
